Galectin Therapeutics
GALT
#8074
Rank
C$0.23 B
Marketcap
$3.73
Share price
1.48%
Change (1 day)
42.95%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$0.14 B

According to Galectin Therapeutics's latest financial reports the company's total liabilities are C$0.14 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31C$72.56 M46.23%
2021-12-31C$49.62 M619.7%
2020-12-31C$6.89 M85.2%
2019-12-31C$3.72 M29.47%
2018-12-31C$2.87 M-22.94%
2017-12-31C$3.73 M-26.54%
2016-12-31C$5.07 M168.97%
2015-12-31C$1.88 M-4.38%
2014-12-31C$1.97 M-25.32%
2013-12-31C$2.64 M61.41%
2012-12-31C$1.63 M-27.28%
2011-12-31C$2.25 M-71.84%
2010-12-31C$8 M54.91%
2009-12-31C$5.16 M260.39%
2008-12-31C$1.43 M-68.94%
2007-12-31C$4.61 M-37.93%
2006-12-31C$7.43 M362.7%
2005-12-31C$1.6 M46.51%
2004-12-31C$1.09 M121.31%
2003-12-31C$0.49 M-52.95%
2002-12-31C$1.05 M20.04%
2001-12-31C$0.87 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.24 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.90 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA